Digestive & Intestinal Remedies (Pharmacies) - Africa

  • Africa
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach €0.68bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.05%, resulting in a market volume of €0.87bn by 2029.
  • In global comparison, most revenue will be generated in China (€3,090.00m in 2024).
  • In relation to total population figures, per person revenues of €0.53 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Mercado
 
Región
 
Comparación de regiones
 
Moneda
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Africa has been experiencing significant growth in recent years. Customer preferences for over-the-counter remedies, coupled with increasing awareness about digestive health, have been driving this growth. Additionally, local special circumstances and underlying macroeconomic factors have also played a role in shaping the market. Customer preferences in Africa have been shifting towards self-medication and seeking remedies from pharmacies. This is partly due to the convenience and accessibility of pharmacies, as well as the increasing availability of a wide range of digestive and intestinal remedies. Customers are becoming more proactive in managing their digestive health and are seeking quick and effective solutions for common ailments such as indigestion, heartburn, and constipation. Trends in the market indicate a growing demand for natural and herbal remedies. African consumers have shown a preference for traditional and plant-based medicines, believing them to be safer and more effective than synthetic alternatives. This has led to an increase in the availability and variety of herbal digestive remedies in pharmacies across the region. Additionally, there is a growing trend of consumers seeking products that address specific digestive issues, such as probiotics for gut health or enzymes for better digestion. Local special circumstances in Africa, such as a high prevalence of gastrointestinal diseases and dietary challenges, have contributed to the growth of the Digestive & Intestinal Remedies market. The region has a higher incidence of diseases such as diarrhea, irritable bowel syndrome, and gastroesophageal reflux disease. This has created a demand for effective remedies that can alleviate symptoms and improve overall digestive health. Furthermore, dietary challenges such as limited access to clean water and poor sanitation practices can also contribute to digestive issues, leading to an increased need for remedies. Underlying macroeconomic factors, such as population growth and rising disposable incomes, have also fueled the growth of the Digestive & Intestinal Remedies market in Africa. As the population continues to increase, so does the demand for healthcare products and services. Additionally, rising disposable incomes have made healthcare more affordable and accessible to a larger segment of the population, leading to increased spending on digestive remedies. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Africa is developing due to customer preferences for over-the-counter remedies, increasing awareness about digestive health, and the availability of a wide range of products. Local special circumstances, such as a high prevalence of gastrointestinal diseases and dietary challenges, have further contributed to the growth of the market. Underlying macroeconomic factors, including population growth and rising disposable incomes, have also played a role in fueling the market's development. As the market continues to evolve, it is expected to witness further growth and innovation in response to changing customer needs and preferences.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Visión general

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Espere, por favor

Contacto

¿Alguna duda? Estaremos encantados de atenderte.
Statista Locations
Contacto Nerea Marcos
Nerea Marcos
Client Success Manager

Lu - vi, 9:30 - 17:00 h (CET)

Contacto Meredith Alda
Meredith Alda
Sales Manager– Contacto (Estados Unidos)

Lu - vi, 9:00 - 18:00 h (EST)

Contacto Yolanda Mega
Yolanda Mega
Operations Manager– Contacto (Asia)

Lu - vi, 9:00 - 17:00 h (SGT)

Contacto Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contacto (Asia)

Lu - vi, 10:00 - 18:00 h (JST)

Contacto Lodovica Biagi
Lodovica Biagi
Director of Operations– Contacto (Europa)

Lu - vi, 9:30 - 17:00 h (GMT)

Contacto Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contacto (América Latina)

Lu - vi, 9:00am-6:00pm (EST)